A physician must review full medical history before use
26, 2025 /PRNewswire/ -- In response to the growing interest in glucagon-like peptide-1 (GLP-1) weight-loss medications and the cost challenges employers face to offer coverage, Liviniti, a national leader in PBM innovation, has introduced a breakthrough solution to help manage the expense that comes with increased access to these high-cost but effective treatments
Interestingly, even though the parameter bounds for the optimization were allowed to search for increasing or decreasing values, the DEN therapy optimization converged unguided to a lower blood glucose and higher blood -hydroxybutyrate, blood lactate, and NAD-modulation, consistent with commonly accepted benefits of calorie restriction, exercise, and NAD supplementation (58)
Indeed, it was recently reported that SAC can also increase levels of cGMP, which is well known to induce vasodilation